| 英文名稱 | Azeliragon (TTP488) |
|---|---|
| 中文名稱 | 阿齊瑞格 |
| CAS號(hào) | 603148-36-3 |
| 分子式 | C32H38ClN3O2 |
| 分子量 | 532.13 |
| 外觀 | White to off-white powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| 規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
|---|---|---|---|---|
| 5 mg | In-stock | ¥1000.00 | 登錄后可見(jiàn) | |
| 10 mg | In-stock | ¥1660.00 | 登錄后可見(jiàn) | |
| 20 mg | In-stock | ¥2800.00 | 登錄后可見(jiàn) |
| 英文名稱 | Azeliragon (TTP488) |
|---|---|
| 中文名稱 | 阿齊瑞格 |
| CAS號(hào) | 603148-36-3 |
| 分子式 | C32H38ClN3O2 |
| 分子量 | 532.13 |
| 外觀 | White to off-white powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Azeliragon (TTP488, PF-04494700) is an orally bioavailable small molecule that inhibits the receptor for advanced glycation endproducts (RAGE), which is an immunoglobulin-like cell surface receptor overexpressed in brain tissues of patients with AD.